Weimin Peng

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Javier Muñoz, André Goy et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Medicine, Hematology, Oncology +15

Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer

Howard I. Scher, Glenn Heller, Arturo Molina et al. · Journal of Clinical Oncology · 2015 · 382 citations · Full text

Medicine, Oncology, Pharmacology +17

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang, Javier Muñoz, André Goy et al. · Journal of Clinical Oncology · 2022 · 318 citations · Full text

Medicine, Hematology, Oncology +15

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

Mary-Ellen Taplin, Bruce Montgomery, Christopher J. Logothetis et al. · Journal of Clinical Oncology · 2014 · 281 citations · Full text

Medicine, Oncology, Urology +17

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone

Eleni Efstathiou, John W. Davis, Louis L. Pisters et al. · European Urology · 2019 · 83 citations · Full text

Medicine, Oncology, Urology +17